| NCT ID | NCT07593313 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nanchong Central Hospital |
| Condition | Central Post-Stroke Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2024-01-01 |
| Primary Completion | 2026-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2024-01-01 with a primary completion date of 2026-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To evaluate the short-term analgesic efficacy of stSCS combined with pharmacotherapy compared with pharmacotherapy alone in patients with CPSP, measured by Numerical Rating Scale (NRS) score immediately after treatment.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of central post-stroke pain (CPSP) according to the International Association for the Study of Pain (IASP) criteria * Clear history of stroke confirmed by cranial CT or MRI * Pain occurring after stroke and distributed in body parts corresponding to central nervous system injury * Pain with neuropathic characteristics (e.g., burning sensation, electric shock sensation, needle prick sensation) * Pain not explained by other causes * Age ≥ 18 years * Pain duration ≥ 3 months * Baseline pain Numerical Rating Scale (NRS) score ≥ 4 points * Complete clinical data with follow-up time ≥ 6 months Exclusion Criteria: * History of chronic pain before stroke * Severe cognitive impairment that prevents cooperation with pain assessment (Mini-Mental State Examination, MMSE \< 15 points) * Contraindications to spinal cord stimulation (SCS), such as coagulation disorders, active infections, or mental diseases that prevent cooperation * Malignant tumors or other severe organic diseases with expected survival \< 1 year
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07593313 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Central Post-Stroke Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07593313 currently recruiting?
Yes, NCT07593313 is actively recruiting participants. Contact the research team at gaozhenguo0822@163.com for enrollment information.
Where is the NCT07593313 trial being conducted?
This trial is being conducted at Nanchong, China.
Who is sponsoring the NCT07593313 clinical trial?
NCT07593313 is sponsored by Nanchong Central Hospital. The trial plans to enroll 80 participants.
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.